NeuroPro Therapeutics

Yachats, United States

NeuroPro Therapeutics is a pharmaceutical company that develops drugs to treat epilepsy and other neurological disorders.

$5.1M raised

Apr 2023

Venture - Series Unknown

Biotechnology Life Science Neuroscience Pharmaceutical Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NeuroPro Therapeutics

How much funding has NeuroPro Therapeutics raised?

NeuroPro Therapeutics has raised $5.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2023.

Where is NeuroPro Therapeutics headquartered?

NeuroPro Therapeutics is headquartered in Yachats, United States.

What does NeuroPro Therapeutics do?

NeuroPro Therapeutics is a pharmaceutical company that develops drugs to treat epilepsy and other neurological disorders.

What stage is NeuroPro Therapeutics at?

NeuroPro Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 13, 2023.

MLA

"NeuroPro Therapeutics — Funding & Investors." VCBacked, April 13, 2023, https://www.vcbacked.co/company/neuropro-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). NeuroPro Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/neuropro-therapeutics

Wikipedia (cite web)

{{cite web |title=NeuroPro Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neuropro-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 13, 2023.